Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 806 of 1,261
  1. US 8771665

    Inhibitors of hepatitis C virus polymerase

    COCRYSTAL, DISCOVERY, INC. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  2. US 8772453

    Compositions for linking zinc finger modules

    Sangamo Biosciences, Inc. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  3. US 8772479

    Oligomer-containing substituted aromatic triazine compounds

    Nektar Therapeutics · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  4. US 8772291

    Multicyclic compounds and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  5. US 8772288

    Substituted spiro[cycloalkyl-1,3′-indo]-2′(1′H)-one derivatives and their use as P38 mitogen-activated kinase inhibitors

    Almirall, S.A. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  6. US 8772247

    Anti-parasitic compounds

    The Regents of the University of California · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  7. EP 2747770

    BEHANDLUNGEN MIT ESLICARBAZEPINACETAT ODER ESLICARBAZEPIN

    BIAL PORTELA & C S A [PT] · Granted Jul 2, 2014 · Expires Jun 27, 2034

    granted
  8. US 8765933

    Asynthesis of β-nucleosides

    PHARMAESSENTIA CORPORATION · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  9. US 8765935

    Nucleosides with antiviral and anticancer activity

    Regents of the University of Minnesota · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  10. US 8765945

    Processes of synthesizing dihydropyridophthalazinone derivatives

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  11. US 8765932

    Compositions and methods for inhibiting expression of XBP-1 gene

    Alnylam Pharmaceuticals, Inc. · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  12. US 8765957

    Process for making modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  13. US 8768431

    Systems and methods for tissue imaging

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  14. US 8765948

    Processes for the preparation of uracil derivatives

    Neurocrine Biosciences, Inc. · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  15. US 8765437

    Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  16. US 8765111

    N-maleimidyl polymer derivatives

    Nektar Therapeutics · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  17. US 8765125

    Methods of treating autoimmune diseases with Dll4 antagonists

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  18. US 8764828

    System and method for forming bone, ligament, and bone-ligament constructs

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  19. US 8765147

    Endophytic fungi from Pteromischum sp. plant, compounds and methods of use

    The Regents of the University of California · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  20. US 8764733

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  21. US 8765141

    Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host

    The United States of America, as represented by the Secretary of Agriculture · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  22. US 8765146

    Adenoviral vector-based malaria vaccines

    United States of America as represented by the Secretary of the Air Force · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  23. US 8765168

    Compositions of a fluorapatite and methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  24. US 8765171

    Methods and compositions for liposomal formulation of antigens and uses thereof

    The Regents of the University of California · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.